Regulation of triosephosphate isomerase (TPI) gene expression in TPI deficient lymphoblastoid cells

International Journal of Molecular Medicine

Volumn 3, Issue 1, 1999, Pages 21-24

  Ationu, Art ^a   Humphries, Ann ^a   Layton, D Mark ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Crythroleukaemia cells; Gene expression; Gene therapy; Messenger RNA; Trioscphosphatc isomcrase

Indexed keywords

DACTINOMYCIN; MESSENGER RNA; NUCLEIC ACID SYNTHESIS INHIBITOR; TRIOSEPHOSPHATE ISOMERASE;

ARTICLE; CELL LINE; CULTURE MEDIUM; CYTOLOGY; DRUG EFFECT; ENZYMOLOGY; GENE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HUMAN; LYMPHOCYTE; METABOLISM; PLASMA;

CELL LINE; CULTURE MEDIA, SERUM-FREE; DACTINOMYCIN; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENES; HUMANS; LYMPHOCYTES; NUCLEIC ACID SYNTHESIS INHIBITORS; PLASMA; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TRIOSE-PHOSPHATE ISOMERASE;

EID: 0032608445     PISSN: 11073756     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijmm.3.1.21     Document Type: Article

References (15)

1. Schneider AS, Dunn I, Ibsen KH and Weinstein IM: Triosephosphate isomerase deficiency. In: Hereditary Disorders of Erythrocyte Metabolism. Beutler E (ed.) Grune and Stratton, New York, pp265-272, 1968.
2. Schneider AS, Valentine WN, Hattori M and Heins JR: Hereditary hemolytic anemia with triosephosphate isomerase deficiency. N Engl J Med 272: 229-235, 1965.
3. Arya R, Layton DM and Bellingham AJ: Hereditary red cell cnzymopathics. Blood Rev 9: 165-175, 1995.
4. Daar IO and Maquat LE: Premature translation termination mediates triosephosphate isomerasc mRNA degradation. Mol Cell Biol 8: 802-813, 1988.
5. Boyer TG and Maquat LE: Minimal sequence and factor requirements for the initiation of transcription from atypical, TATATAA box-containing housekeeping promoter. J Biol Chem 265: 20524-20532, 1990.
6. Mason PJ: Red cell enzyme deficiencies: from genetic basis to transfer. Semin Hematol 35: 126-135, 1998.
7. Schneider A and Cohen-Solal M: Hematologically important mutations-triosephosphate isomerasc. Blood Cells Mol Dis 22: 82-84, 1996.
8. Brown JR, Daar IO, Krug JR and Maquat LE: Characterization of the functional gene and several processed pscudogenes in the human triosephosphate isomerase gene family. Mol Cell Biol 5: 1694-1706, 1985.
9. Ationu A, Humphries A, Bellingham AJ and Layton DM: Metabolic correction of triosephosphate isomerase deficiency in vitro by complementation. Biochem Biophys Res Commun 232: 528-531, 1997.
10. Chomczynski P and Sacchi N: Single step method of RNA isolation by acid guanidinium thiocyanate-phenol chloroform extraction. Anal Biochem 162: 156-159, 1987.
11. Ationu A, Sorensen K, Whitehead B, Singer D, Burch M and Carter ND: Ventricular expression of brain natriuretic peptide gene following orthotopic cardiac transplantation in children - a three year follow up. Cardiovasc Res 27: 2135-2139, 1993.
12. Maquat LE, Chilcote R and Ryan PM: Human triosephosphate isomerase cDNA and protein structures: studies of triosephosphate isomerase deficiency in man. J Biol Chem 260: 3748-3753, 1985.
13. Boyer TG and Maquat LE: Modulation of human triosephosphate isomerasc gene transcript by serum. J Biol Chem 266: 13350-13354, 1991.
14. Li Q, Ding L and Bever CT: Interferon-γ induces cathepsin B expression in a human macrophagc-like cell line by increasing both transcription and mRNA stability. Int J Mol Mcd 2: 181-186, 1998.
15. Ross J: mRNA stability in mammalian cells. Microbiol Rev 59: 423-450, 1995.